EV/EBITDA
12.94
+0.15+1.17%
Mon, 24 Feb 2025 23:03:10 GMT
Summary
- As of February 25, 2025, HALO EV/EBITDA is 12.94, with a rise of +0.15 (+1.17%) during the most recent trading day.
- Over the past year, HALO EV/EBITDA has dropped by -1.50 (-10.39%).
- HALO EV/EBITDA is now -99.59% below its all-time high of 3163.18.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.2% | +1.2% | +1.5% |
| 1 m1 month | - | - | +3.5% |
| 3 m3 months | -1.8% | +11.1% | +16.6% |
| 6 m6 months | -28.1% | -9.2% | -9.1% |
| ytdytd | - | - | +19.9% |
| 1 y1 year | -10.4% | +30.2% | +42.3% |
| 5 y5 years | +122.6% | +161.9% | +169.3% |
HALO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.8% | 12.79 | +1.2% | |
| 3 m | 3-month | 13.28 | -2.6% | 12.46 | +3.9% |
| 6 m | 6-month | 18.37 | -29.6% | 11.70 | +10.6% |
| 1 y | 1-year | 18.37 | -29.6% | 11.70 | +10.6% |
| 3 y | 3-year | 32.43 | -60.1% | 11.70 | +10.6% |
| 5 y | 5-year | 140.85 | -90.8% | -218.09 | +105.9% |
| alltime | all time | 3163.18 | -99.6% | -218.09 | +105.9% |
Halozyme Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 12.94(-3.6%) |
| 2023 | 13.42(-52.7%) |
| 2022 | 28.36(+16.9%) |
| 2021 | 24.27(-38.3%) |
| 2020 | 39.33(-182.2%) |
| 2019 | -47.85(+30.0%) |
| 2018 | -36.82(-207.9%) |
| 2017 | 34.13(-289.8%) |
| 2016 | -17.98(-79.5%) |
| 2015 | -87.86(+346.2%) |
| Date | Value |
|---|---|
| 2014 | -19.69(-10.6%) |
| 2013 | -22.02(+68.0%) |
| 2012 | -13.11(-73.8%) |
| 2011 | -50.13(+270.8%) |
| 2010 | -13.52(+63.7%) |
| 2009 | -8.26(+4.0%) |
| 2008 | -7.94(-52.0%) |
| 2007 | -16.55(-50.1%) |
| 2006 | -33.19(+389.5%) |
| 2005 | -6.78(-34.1%) |
| 2004 | -10.29 |
FAQ
- What is Halozyme Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Halozyme Therapeutics?
- What is Halozyme Therapeutics EV/EBITDA year-on-year change?
What is Halozyme Therapeutics EV/EBITDA?
The current EV/EBITDA of HALO is 12.94
What is the all time high EV/EBITDA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high EV/EBITDA is 3163.18
What is Halozyme Therapeutics EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -1.50 (-10.39%)